De Burlo Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.4M Sell
26,518
-16,260
-38% -$16.5M 5.53% 3
2025
Q4
$46M Sell
42,778
-10
-0% -$9.56K 5.58% 1
2025
Q3
$32.6M Buy
42,788
+14,260
+50% +$10.6M 3.93% 9
2025
Q2
$22.2M Sell
28,528
-3,660
-11% -$2.84M 2.93% 12
2025
Q1
$26.6M Buy
32,188
+8,250
+34% +$6.86M 3.92% 7
2024
Q4
$18.5M Sell
23,938
-16,863
-41% -$14M 2.47% 17
2024
Q3
$36.1M Sell
40,801
-4,240
-9% -$3.81M 4.45% 7
2024
Q2
$40.8M Sell
45,041
-870
-2% -$696K 5.48% 4
2024
Q1
$35.7M Sell
45,911
-7,513
-14% -$5.35M 4.74% 4
2023
Q4
$28.7M Hold
53,424
4.99% 2
2023
Q3
$28.7M Sell
53,424
-147
-0.3% -$75.7K 4.99% 2
2023
Q2
$25.1M Buy
53,571
+43,391
+426% +$18.2M 4.18% 4
2023
Q1
$3.5M Sell
10,180
-44,650
-81% -$15.1M 0.68% 41
2022
Q4
$20.1M Buy
54,830
+11,256
+26% +$3.99M 4.48% 4
2022
Q3
$14.1M Buy
43,574
+40,619
+1,375% +$12.9M 3.35% 10
2022
Q2
$958K Sell
2,955
-3,489
-54% -$1.05M 0.27% 31
2022
Q1
$1.85M Sell
6,444
-450
-7% -$116K 0.34% 48
2021
Q4
$1.9M Hold
6,894
0.28% 59
2021
Q3
$1.59M Hold
6,894
0.26% 61
2021
Q2
$1.58M Buy
6,894
+300
+5% +$60.3K 0.25% 56
2021
Q1
$1.23M Hold
6,594
0.22% 59
2020
Q4
$1.11M Buy
6,594
+5,080
+336% +$758K 0.18% 58
2020
Q3
$224K Buy
+1,514
New +$234K 0.04% 80
2020
Q1
Sell
-1,614
Closed -$212K 75
2019
Q4
$212K Buy
+1,614
New +$187K 0.04% 80
2019
Q2
Sell
-68,414
Closed -$8.88M 90
2019
Q1
$8.88M Sell
68,414
-44,400
-39% -$5.4M 1.79% 26
2018
Q4
$13.1M Buy
112,814
+34,900
+45% +$3.9M 2.93% 7
2018
Q3
$8.36M Buy
+77,914
New +$7.79M 1.57% 18

Other funds holding LLY

De Burlo Group's LLY Position: Q1 2026 in Review

De Burlo Group reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $16.5M and leaving 26,518 shares worth $24.4M. The position accounts for 5.53% of the portfolio, ranked #3.

De Burlo Group first reported a position in LLY in Q3 2018 and has held it in 27 quarters since. The position peaked at $46M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • De Burlo Group held 26,518 shares of Eli Lilly worth $24.4M as of Q1 2026.
  • De Burlo Group sold 16,260 Eli Lilly shares in Q1 2026, an estimated $16.5M.
  • Eli Lilly made up 5.53% of De Burlo Group's portfolio in Q1 2026, its #3 holding.
  • De Burlo Group first reported a position in Eli Lilly in Q3 2018 and has held it in 27 quarters since.
  • De Burlo Group's Eli Lilly position peaked at $46M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on De Burlo Group's 13F filing for Q1 2026, filed 14 May 2026.